Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 185

Similar articles for PubMed (Select 14720503)

1.

Altered Notch signaling resulting from expression of a WAMTP1-MAML2 gene fusion in mucoepidermoid carcinomas and benign Warthin's tumors.

Enlund F, Behboudi A, Andrén Y, Oberg C, Lendahl U, Mark J, Stenman G.

Exp Cell Res. 2004 Jan 1;292(1):21-8.

PMID:
14720503
2.

t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway.

Tonon G, Modi S, Wu L, Kubo A, Coxon AB, Komiya T, O'Neil K, Stover K, El-Naggar A, Griffin JD, Kirsch IR, Kaye FJ.

Nat Genet. 2003 Feb;33(2):208-13. Epub 2003 Jan 21. Erratum in: Nat Genet. 2003 Mar;33(3):430.

PMID:
12539049
3.

Clear cell hidradenoma of the skin-a third tumor type with a t(11;19)--associated TORC1-MAML2 gene fusion.

Behboudi A, Winnes M, Gorunova L, van den Oord JJ, Mertens F, Enlund F, Stenman G.

Genes Chromosomes Cancer. 2005 Jun;43(2):202-5.

PMID:
15729701
4.

Molecular classification of mucoepidermoid carcinomas-prognostic significance of the MECT1-MAML2 fusion oncogene.

Behboudi A, Enlund F, Winnes M, Andrén Y, Nordkvist A, Leivo I, Flaberg E, Szekely L, Mäkitie A, Grenman R, Mark J, Stenman G.

Genes Chromosomes Cancer. 2006 May;45(5):470-81.

PMID:
16444749
5.

[Significance of molecular-cytogenetic findings in mucoepidermoid carcinoma as an example of salivary gland tumors].

Röser K, Jäkel KT, Bullerdiek J, Löning T.

Pathologe. 2005 Sep;26(5):359-66. Review. German.

PMID:
16075259
6.

CRTC1/MAML2 fusion transcript in high grade mucoepidermoid carcinomas of salivary and thyroid glands and Warthin's tumors: implications for histogenesis and biologic behavior.

Tirado Y, Williams MD, Hanna EY, Kaye FJ, Batsakis JG, El-Naggar AK.

Genes Chromosomes Cancer. 2007 Jul;46(7):708-15.

PMID:
17437281
7.

A closer look at Warthin tumors and the t(11;19).

Fehr A, Röser K, Belge G, Löning T, Bullerdiek J.

Cancer Genet Cytogenet. 2008 Jan 15;180(2):135-9. doi: 10.1016/j.cancergencyto.2007.10.007.

PMID:
18206539
8.

A study of MECT1-MAML2 in mucoepidermoid carcinoma and Warthin's tumor of salivary glands.

Martins C, Cavaco B, Tonon G, Kaye FJ, Soares J, Fonseca I.

J Mol Diagn. 2004 Aug;6(3):205-10.

9.

t(11;19) translocation and CRTC1-MAML2 fusion oncogene in mucoepidermoid carcinoma.

O'Neill ID.

Oral Oncol. 2009 Jan;45(1):2-9. doi: 10.1016/j.oraloncology.2008.03.012. Epub 2008 May 16. Review.

PMID:
18486532
10.

New insights into the nature of Warthin's tumour.

O'Neill ID.

J Oral Pathol Med. 2009 Jan;38(1):145-9. doi: 10.1111/j.1600-0714.2008.00676.x. Epub 2008 Jul 21. Review.

PMID:
18647217
11.

Aberrantly activated AREG-EGFR signaling is required for the growth and survival of CRTC1-MAML2 fusion-positive mucoepidermoid carcinoma cells.

Chen Z, Chen J, Gu Y, Hu C, Li JL, Lin S, Shen H, Cao C, Gao R, Li J, Ha PK, Kaye FJ, Griffin JD, Wu L.

Oncogene. 2014 Jul 17;33(29):3869-77. doi: 10.1038/onc.2013.348. Epub 2013 Aug 26.

PMID:
23975434
12.

Clinicopathological significance of the CRTC3-MAML2 fusion transcript in mucoepidermoid carcinoma.

Nakayama T, Miyabe S, Okabe M, Sakuma H, Ijichi K, Hasegawa Y, Nagatsuka H, Shimozato K, Inagaki H.

Mod Pathol. 2009 Dec;22(12):1575-81. doi: 10.1038/modpathol.2009.126. Epub 2009 Sep 11.

13.

CRTC1/MAML2 fusion transcript in Warthin's tumor and mucoepidermoid carcinoma: evidence for a common genetic association.

Bell D, Luna MA, Weber RS, Kaye FJ, El-Naggar AK.

Genes Chromosomes Cancer. 2008 Apr;47(4):309-14. doi: 10.1002/gcc.20534.

PMID:
18181164
14.

Sustained expression of Mect1-Maml2 is essential for tumor cell growth in salivary gland cancers carrying the t(11;19) translocation.

Komiya T, Park Y, Modi S, Coxon AB, Oh H, Kaye FJ.

Oncogene. 2006 Oct 5;25(45):6128-32. Epub 2006 May 1.

PMID:
16652146
15.

MECT1-MAML2 fusion transcript defines a favorable subset of mucoepidermoid carcinoma.

Okabe M, Miyabe S, Nagatsuka H, Terada A, Hanai N, Yokoi M, Shimozato K, Eimoto T, Nakamura S, Nagai N, Hasegawa Y, Inagaki H.

Clin Cancer Res. 2006 Jul 1;12(13):3902-7.

16.

A reappraisal of the MECT1/MAML2 translocation in salivary mucoepidermoid carcinomas.

Seethala RR, Dacic S, Cieply K, Kelly LM, Nikiforova MN.

Am J Surg Pathol. 2010 Aug;34(8):1106-21. doi: 10.1097/PAS.0b013e3181de3021.

PMID:
20588178
17.

Mect1-Maml2 fusion oncogene linked to the aberrant activation of cyclic AMP/CREB regulated genes.

Coxon A, Rozenblum E, Park YS, Joshi N, Tsurutani J, Dennis PA, Kirsch IR, Kaye FJ.

Cancer Res. 2005 Aug 15;65(16):7137-44.

18.

Prognostic significance of p27Kip1, Ki-67, and CRTC1-MAML2 fusion transcript in mucoepidermoid carcinoma: a molecular and clinicopathologic study of 101 cases.

Miyabe S, Okabe M, Nagatsuka H, Hasegawa Y, Inagaki A, Ijichi K, Nagai N, Eimoto T, Yokoi M, Shimozato K, Inagaki H.

J Oral Maxillofac Surg. 2009 Jul;67(7):1432-41. doi: 10.1016/j.joms.2009.03.021.

PMID:
19531414
19.

WIF1, an inhibitor of the Wnt pathway, is rearranged in salivary gland tumors.

Queimado L, Lopes CS, Reis AM.

Genes Chromosomes Cancer. 2007 Mar;46(3):215-25.

PMID:
17171686
20.

CRTC1 rearrangements in the absence of t(11;19) in primary cutaneous mucoepidermoid carcinoma.

Lennerz JK, Perry A, Dehner LP, Pfeifer JD, Lind AC.

Br J Dermatol. 2009 Oct;161(4):925-9. doi: 10.1111/j.1365-2133.2009.09200.x. Epub 2009 Apr 29.

PMID:
19438452
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk